-
Jan 17, 2025 | 
mondaq.com | Richard Kelly
On December 20 the Federal Circuit in Teva BrandedPharmaceutical Products R&D, Inc. (Teva)v. Amneal Pharmaceuticals (Amneal) affirmed the districtcourt's decision that medical devices were not listable in theOrange Book and Teva had improperly listed patents in the OrangeBook and required Teva to remove them. Medical devices which serve as both packaging for a drug anddrug delivery device are considered by the FDA to be combinationproducts treated as drugs for regulatory purposes.
-
Oct 4, 2024 | 
mondaq.com | Richard Kelly
In Astellas Pharma Inc. v. Sandoz Inc,, et al,
following a five-day patent claims bench trial the court found
asserted claims 5, 20, and 25 invalid under 35 U.S.C. § 101
even though Sandoz had not asserted 101 as defense at any time
during the case. The parties had agreed to limit the issue to
claims 5, 20, and 25 and the defense to invalidity under 35 U.S.C.
§ 112. Neither party had notice that patent eligibility was an
issue.
-
Aug 30, 2024 | 
mondaq.com | Richard Kelly
In Allergan USA, Inc v Sun Pharmaceutical Indus. Ltd,
Appeal No. 2024-1061, August 13, 2024, the Federal Circuit reversed
the district court's holding that Allergan patent, U.S.P.
7,741,356 ('356) was invalid for obviousness-type double
patenting over USPs 11,007,179, 11,090,291, and 11,311,516. The
relationship between the patents is shown below:
The '356 patent was entitled to significant PTA but because
of the PTE it received, Allergan effectively disclaimed all but 487
days of the PTA.
-
Jul 19, 2024 | 
commonslibrary.parliament.uk | Richard Kelly
The House elects the chairs of a number of select committees, under Standing Order No 122B. On the day after the election of the Speaker, the new Speaker informs the House which parties are entitled to select committee chairs that will be elected by the House and how many. The parties then propose which committees each will chair and put a motion before the House. When this motion has been agreed, the Speaker confirms the timetable for nominating and electing chairs.
-
Jun 2, 2024 | 
comingsoon.it | Richard Kelly
PANORAMICA SU DONNIE DARKO Donnie Darko è il film indipendente americano che ha segnato il debutto dietro la macchina da presa di Richard Kelly, anche sceneggiatore.
-
May 16, 2024 | 
interviewmagazine.com | Richard Kelly |Emily Sandstrom
Since its premiere at Sundance earlier this year, the nostalgic thriller I Saw The TV Glow has been enthusiastically hailed as Gen Z’s Donnie Darko. Director Jane Schoenbrun’s third feature takes a hazy trip back to the 90’s, where a pair of teen outcasts, stuck in the clutches of a suffocating suburban youth, take solace in a supernatural television show that soon becomes a point of obsession.
-
Feb 23, 2024 | 
mondaq.com | Richard Kelly
The Federal Circuit on February 9 decided another written
description case involving a range not found in ipsis
verbis in the patent specification in RAI Strategic
Holdings Inc. v. Philip Morris Products S.A. RAI
appealed from a PTAB holding in PGR2020-00071 that claims 10 and 27
of U.S.P. 10,492,542 lacked written description in the
specification. Claims 27 is reproduced below; claim 10 is identical
except it depends on claim 9:
27.
-
Feb 6, 2024 | 
filmstarts.de | Richard Kelly
auf DVD|1 Std. 53 Min. |Drama,Sci-FiWiederaufführungsterminRegie:Richard Kelly|Drehbuch:Richard KellyBesetzung:Jake Gyllenhaal,Jena Malone,Drew BarrymoreOriginaltitel: Donnie Darko Pressekritiken User-Wertung 4,2 1179 Wertungen, 37 KritikenBewerte :0.511.522.533.544.55InhaltsangabeFSK ab 16 freigegebenMiddlesex, ein typischer amerikanischer Vorort – hier lebt Donnie Darko (Jake Gyllenhaal), ein auf den ersten Blick ganz normaler Teenager.
-
Jan 30, 2024 | 
thoughtsfromthemountaintop.com | Patti Aliventi |Richard Kelly
Written by Richard KellyDirected by Richard KellyBack around 2008, I’d heard so much about the film Donnie Darko, and yet I still didn’t know what I was in for when I finally watched it. Although parts of the story became clear early on, some of it even after the film was over left me scratching my head. That’s not to say it wasn’t a good film – it’s just one of those films that work quite well with repeat viewing as some nuances are captured then.
-
Jan 15, 2024 | 
mondaq.com | Richard Kelly
The USPTO today published its guidance to the examiners on the
impact of the Amgen v. Sanofi,143 S. Ct. 1243 (2023), on
USPTO practice. The Guidance is basically steady as she goes but
with the caveat that the enablement requirement and the
Wands factors (In re Wands, 858 F.2d 731, 737
(Fed. Cir. 1988)) apply across all technologies, noting the
Court's reliance on cases involving the telegraph, incandescent
lamp filaments and wood glue.
